Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management
References
- Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Science Translational Medicine. 2012; 4(127): 127rv124. DOI: 10.1126/scitranslmed.3003218
- Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins: Genetic and nongenetic familial risk factors. J Natl Cancer Inst. 1997; 89(4): 287–293. DOI: 10.1093/jnci/89.4.287
- Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2): 78–85. DOI: 10.1056/NEJM200007133430201
- Cortes J, Perez-Garcia JM, Llombart-Cussac A, et al. Enhancing global access to cancer medicines. CA Cancer J Clin. 2020; 70(2): 105–124. DOI: 10.3322/caac.21597
- Offit K. Decade in review—genomics: A decade of discovery in cancer genomics. Nature Reviews Clinical Oncology. 2014; 11(11): 632–634. DOI: 10.1038/nrclinonc.2014.170
- Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: Setting paradigms in personalized cancer care and prevention. Science. 2014; 343(6178): 1466–1470. DOI: 10.1126/science.1251827
- Mandelker D, Zhang L, Kemel Y, et al. Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing. JAMA. 2017; 318(9): 825–835. DOI: 10.1001/jama.2017.11137
- Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002; 346(21): 1609–15. DOI: 10.1056/NEJMoa020119
- Järvinen HJ, Renkonen-Sinisalo L, Aktán-Collán K, Peltomäki P, Aaltonen LA, Mecklin JP. Ten years after mutation testing for Lynch syndrome: Cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol. 2009; 27(28): 4793–7. DOI: 10.1200/JCO.2009.23.7784
- Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP, et al. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: A double-blind, randomised, placebo-controlled trial. Lancet. 2020; 395(10240): 1855–1863. DOI: 10.1016/S0140-6736(20)30366-4
- Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E, et al. Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol. 2021; 39(24): 2698–2709. DOI: 10.1200/JCO.20.03661
- Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019; 37(15): 1305–1315. DOI: 10.1200/JCO.18.01854
- Williams CD, Bullard AJ, O’Leary M, Thomas R, Redding TS,
4th , Goldstein K. Racial/ethnic disparities in BRCA counseling and testing: A narrative review. J Racial Ethn Health Disparities. 2019; 6(3): 570–583. DOI: 10.1007/s40615-018-00556-7 - Mittendorf KF, Knerr S, Kauffman TL, Lindberg NM, Anderson KP, Feigelson HS, et al. Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: Implications for health care inequities. JCO Precis Oncol. 2021; 5: PO.21.00233. DOI: 10.1200/PO.21.00233
- Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, et al. J Natl Compr Canc Netw. 2021; 19(1): 77–102.
- Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007; 25: 3985–3990. DOI: 10.1200/JCO.2007.12.2622
- Feitosa J, das Chagas PF, de Sousa GR, et al. Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors. Mol Biol Rep. 2020; 47(8): 6439–6443. DOI: 10.1007/s11033-020-05655-5
- Cline MS, Liao RG, Parsons MT, et al. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018; 14(12):
e1007752 . DOI: 10.1371/journal.pgen.1007752 - Toland AE, Forman A, Couch FJ, et al. Clinical testing of BRCA1 and BRCA2: A worldwide snapshot of technological practices. NPJ Genom Med. 2018; 3: 7. DOI: 10.1038/s41525-018-0046-7
- Wauters A, Van Hoyweghen I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J Hum Genet. 2016; 61(4): 275–282. DOI: 10.1038/jhg.2015.151
- Otlowski M, Taylor S, Bombard Y. Genetic discrimination: international perspectives. Annu Rev Genomics Hum Genet. 2012; 13: 433–454. DOI: 10.1146/annurev-genom-090711-163800
- Abacan M, Alsubaie L, Barlow-Stewart K, et al. The Global State of the Genetic Counseling Profession. Eur J Hum Genet. 2019; 27(2): 183–197. DOI: 10.1038/s41431-018-0252-x
- Berninger T, Nusbaum R, Redlinger-Grosse K, Davis C, Reiser C. A narrative literature review: Growing the workforce through increased fieldwork capacity in genetic counseling training programs. J Genet Couns. 2021; 30(2): 574–587. DOI: 10.1002/jgc4.1346
- Bertagnolli MM, Sartor O, Chabner BA, et al. Advantages of a truly open-access data-sharing model. N Engl J Med. 2017; 376(12): 1178–1181. DOI: 10.1056/NEJMsb1702054
- Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401–404. DOI: 10.1158/2159-8290.CD-12-0095
- Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): l1. DOI: 10.1126/scisignal.2004088
- Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020; 383(7): 640–649. DOI: 10.1056/NEJMoa1916623
- Sudlow C, Gallacher J, Allen N, et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015; 12(3):
e1001779 . DOI: 10.1371/journal.pmed.1001779
DOI: https://doi.org/10.5334/aogh.3967 | Journal eISSN: 2214-9996
Language: English
Submitted on: Sep 17, 2022
Accepted on: Dec 22, 2022
Published on: Feb 21, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Ghassan K. Abou-Alfa, Larry Norton, The Global Oncology Medical Diplomacy Working Group, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.